Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;18(11):2597-2604.
doi: 10.5664/jcsm.10170.

Sleep reactivity predicts insomnia in patients diagnosed with breast cancer

Affiliations

Sleep reactivity predicts insomnia in patients diagnosed with breast cancer

Aliyah Rehman et al. J Clin Sleep Med. .

Abstract

Study objectives: To examine the role of sleep reactivity as a predictor of insomnia in patients diagnosed with breast cancer.

Methods: A total of 173 women with breast cancer participated and were followed up over a period of 9 months. At baseline, participants were assigned to a high (n = 114) or low (n = 59) sleep reactivity group, based on their responses to the Ford Insomnia Response to Stress Test (FIRST). We assessed whether these FIRST groupings (high/low sleep reactivity) predicted changes in insomnia over time using the Insomnia Severity Index. We also tested if these FIRST groupings predicted insomnia disorder (using Insomnia Severity Index cutoffs) at 3 different time points (T3, T6, and T9).

Results: Individuals with high sleep reactivity were more likely to experience a worsening of insomnia. Using logistic regression, we also found that FIRST grouping predicted insomnia disorder. Results remained significant after controlling for estimated premorbid sleep, age, and whether someone had chemotherapy.

Conclusions: Our study shows that sleep reactivity may be a robust predictor of insomnia within breast cancer populations. Sleep reactivity should be considered in routine clinical assessments as a reliable way to identify patients at risk of developing insomnia. This would facilitate early sleep intervention for those patients who are considered high risk.

Citation: Rehman A, Drake CL, Shiramizu V, Fleming L. Sleep reactivity predicts insomnia in patients diagnosed with breast cancer. J Clin Sleep Med. 2022;18(11):2597-2604.

Keywords: Ford Insomnia Response to Stress Test; breast cancer; chemotherapy; insomnia; sleep; sleep reactivity.

PubMed Disclaimer

Conflict of interest statement

All authors approved the final manuscript as submitted. This study was funded by Breast Cancer Now (awarded to Dr. Fleming; ref. 2010MayPR07). The authors report no conflicts of interest.

Figures

Figure 1
Figure 1. The interaction effect between time and reactivity on ISI scores.
The box plots and distributions represent the average ISI scores. The box plots are showing the median, first and third quartile, and the minimum and maximum ISI score for high reactivity (green) and low reactivity (yellow). The distribution “clouds” also give more information about patterns in the data—for example, more or less overlap in average ISI scores between high and low reactivity groups. ISI = Insomnia Severity Index.

Similar articles

Cited by

References

    1. World Health Organization . Cancer. Published 2021. . https://www.who.int/news-room/fact-sheets/detail/cancer . Accessed June 5, 2022.
    1. Cancer Research UK . Breast Cancer Statistics. Published 2016. . https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... . Accessed June 5, 2022.
    1. Koch L , Jansen L , Herrmann A , et al. . Quality of life in long-term breast cancer survivors—a 10-year longitudinal population-based study . Acta Oncol. 2013. ; 52 ( 6 ): 1119 – 1128 . - PubMed
    1. Gehrman PR , Garland SN , Matura LA , Mao J . Insomnia in breast cancer: independent symptom or symptom cluster? Palliat Support Care. 2017. ; 15 ( 3 ): 369 – 375 . - PubMed
    1. Götze H , Taubenheim S , Dietz A , Lordick F , Mehnert A . Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics . J Cancer Surviv. 2018. ; 12 ( 5 ): 712 – 720 . - PubMed

Publication types